Gene-by-gene analysis in the MAGNITUDE study of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations.
暂无分享,去创建一个
E. Small | D. Rathkopf | D. Olmos | M. Gormley | E. Efstathiou | K. Chi | G. Attard | G. Mason | S. Sandhu | Matthew R. Smith | G. Roubaud | George C. Wang | E. Castro | M. Saad | D. Tural | Shibu Thomas | A. J. Gomes | K. Urtishak | B. Diorio | A. Lopez-Gitlitz